Effect of gender on T-cell proliferative responses to myelin proteolipid protein antigens in patients with multiple sclerosis and controls

Journal of Autoimmunity

Volumn 22, Issue 4, 2004, Pages 345-352

  Greer, Judith M ^a,b   Csurhes, Peter A ^a   Pender, Michael P ^a   McCombe, Pamela A ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; MYELIN BASIC PROTEIN; PROTEOLIPID PROTEIN;

ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOREACTIVITY; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE; T LYMPHOCYTE;

AMINO ACID SEQUENCE; AUTOANTIGENS; CASE-CONTROL STUDIES; FEMALE; HUMANS; IMMUNODOMINANT EPITOPES; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MULTIPLE SCLEROSIS; MYELIN BASIC PROTEINS; MYELIN PROTEOLIPID PROTEIN; PEPTIDE FRAGMENTS; SEX CHARACTERISTICS; T-LYMPHOCYTES;

EID: 2142696842     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaut.2004.03.004     Document Type: Article

References (55)

1. Lacroix-Desmazes S., Kaveri S.V., Mouthon L., Ayouba A., Malanchere E., Coutinho A., et al. Self-reactive antibodies (natural autoantibodies) in healthy individuals. J Immunol Methods. 216:1998;117-137
2. Budinger L., Borradori L., Yee C., Eming R., Ferencik S., Grosse-Wilde H., et al. Identification and characterization of autoreactive T cell responses to bullous pemphigoid antigen 2 in patients and healthy controls. J Clin Invest. 102:1998;2082-2089
3. Hattori N., Kuwana M., Kaburaki J., Mimori T., Ikeda Y., Kawakami Y. T cells that are autoreactive to β2-glycoprotein I in patients with antiphospholipid syndrome and healthy individuals. Arthritis Rheum. 43:2000;65-75
4. Goebels N., Hofstetter H., Schmidt S., Brunner C., Wekerle H., Hohlfeld R. Repertoire dynamics of autoreactive T cells in multiple sclerosis patients and healthy subjects: epitope spreading versus clonal persistence. Brain. 123:2000;508-518
5. Pender M.P., Csurhes P.A., Greer J.M., Mowat P.D., Henderson R.D., Cameron K.D., et al. Surges of increased T cell reactivity to an encephalitogenic region of myelin proteolipid protein occur more often in patients with multiple sclerosis than in healthy subjects. J Immunol. 165:2000;5322-5331
6. Tejada-Simon M.V., Hong J., Rivera V.M., Zhang J.Z. Reactivity pattern and cytokine profile of T cells primed by myelin peptides in multiple sclerosis and healthy individuals. Eur J Immunol. 31:2001;907-917
7. Takahashi K., Honeyman M.C., Harrison L.C. Cytotoxic T cells to an epitope in the islet autoantigen IA-2 are not disease specific. Clin Immunol. 99:2001;360-364
8. Burns J.B., Bartholomew B.D., Lobo S.T. In vivo activation of myelin oligodendrocyte glycoprotein-specific T cells in healthy control subjects. Clin Immunol. 105:2002;185-191
9. Pender M.P., Csurhes P.A., Houghten R.A., McCombe P.A., Good M.F. A study of human T-cell lines generated from multiple sclerosis patients and controls by stimulation with peptides of myelin basic protein. J Neuroimmunol. 70:1996;65-74
10. Seo S.J., Fields M.L., Buckler J.L., Reed A.J., Mandik-Nayak L., Nish S.A., et al. The impact of T helper and T regulatory cells on the regulation of anti-double-stranded DNA B cells. Immunity. 16:2002;535-546
11. +cells: a naturally occurring population of regulatory T cells. Blood. 98:2001;2736-2744
12. Arnold B., Schonrich G., Hammerling G. Multiple levels of peripheral tolerance. Immunol Today. 14:1993;12-14
13. Lombardi G., Sidhu S., Batchelor R., et al. Anergic T cells as suppressor cells in vitro. Science. 264:1994;1587-1589
14. Pender M.P. Activation-induced apoptosis of autoreactive and alloreactive T lymphocytes in the target organ as a major mechanism of tolerance. Immunol Cell Biol. 77:1999;216-223
15. O'Connor K.C., Bar-Or A., Hafler D.A. The neuroimmunology of multiple sclerosis: possible roles of T and B lymphocytes in immunopathogenesis. J Clin Immunol. 21:2001;81-92
16. Zamvil S.S., Steinman L. Diverse targets for intervention during inflammatory and neurodegenerative phases of multiple sclerosis. Neuron. 38:2003;685-688
17. Stinissen P., Medaer R., Raus J. Myelin reactive T cells in the autoimmune pathogenesis of multiple sclerosis. Mult Scler. 4:1998;203-211
18. Keegan B.M., Noseworthy J.H. Multiple sclerosis. Annu Rev Med. 53:2002;285-302
19. Weinshenker B.G., Bass B., Rice G.P., Noseworthy J., Carriere W., Baskerville J., et al. The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability. Brain. 112:1989;133-146
20. Greer J.M., Csurhes P.A., Cameron K.D., McCombe P.A., Good M.F., Pender M.P. Increased immunoreactivity to two overlapping peptides of myelin proteolipid protein in multiple sclerosis. Brain. 120:1997;1447-1460
21. Tejada-Simon M.V., Hong J., Rivera V.M., Zhang J.Z. Reactivity pattern and cytokine profile of T cells primed by myelin peptides in multiple sclerosis and healthy individuals. Eur J Immunol. 31:2001;907-917
22. Trotter J.L., Pelfrey C.M., Trotter A.L., Selvidge J.A., Gushleff K.C., Mohanakumar T., et al. T cell recognition of myelin proteolipid protein and myelin proteolipid protein peptides in the peripheral blood of multiple sclerosis and control subjects. J Neuroimmunol. 84:1998;172-178
23. Pelfrey C.M., Cotleur A.C., Lee J.C., Rudick R.A. Sex differences in cytokine responses to myelin peptides in multiple sclerosis. J Neuroimmunol. 130:2002;211-223
24. Lisak R.P., Zweiman B. In vitro cell-mediated immunity of cerebrospinal-fluid lymphocytes to myelin basic protein in primary demyelinating diseases. N Engl J Med. 297:1977;850-853
25. Brinkman C.J., Nillesen W.M., Hommes O.R., Lamers K.J., de Pauw B.E., Delmotte P. Cell-mediated immunity in multiple sclerosis as determined by sensitivity of different lymphocyte populations to various brain tissue antigens. Ann Neurol. 11:1982;450-455
26. Baxevanis C.N., Reclos G.J., Servis C., Anastasopoulos E., Arsenis P., Katsiyiannis A., et al. Peptides of myelin basic protein stimulate T lymphocytes from patients with multiple sclerosis. J Neuroimmunol. 22:1989;23-30
27. Johnson D., Hafler D.A., Fallis R.J., Lees M.B., Brady R.O., Quarles R.H., et al. Cell-mediated immunity to myelin-associated glycoprotein, proteolipid protein, and myelin basic protein in multiple sclerosis. J Neuroimmunol. 13:1986;99-108
28. Kerlero de Rosbo N., Milo R., Lees M.B., Burger D., Bernard C.C., Ben-Nun A. Reactivity to myelin antigens in multiple sclerosis. Peripheral blood lymphocytes respond predominantly to myelin oligodendrocyte glycoprotein. J Clin Invest. 92:1993;2602-2608
29. Acarin N., Rio J., Fernandez A.L., Tintore M., Duran I., Galan I., et al. Different antiganglioside antibody pattern between relapsing-remitting and progressive multiple sclerosis. Acta Neurol Scand. 93:1996;99-103
30. Sadatipour B.T., Greer J.M., Pender M.P. Increased circulating antiganglioside antibodies in primary and secondary progressive multiple sclerosis. Ann Neurol. 44:1998;980-983
31. Mata S., Lolli F., Soderstrom M., Pinto F., Link H. Multiple sclerosis is associated with enhanced B cell responses to the ganglioside GD1a. Mult Scler. 5:1999;379-388
32. Pender M.P., Csurhes P.A., Wolfe N.P., Hooper K.D., Good M.F., McCombe P.A., et al. Increased circulating T cell reactivity to GM3 and GQ1b gangliosides in primary progressive multiple sclerosis. J Clin Neurosci. 10:2003;63-66
33. Hammond S.R., de Wytt C., Maxwell I.C., Landy P.J., English D., McLeod J.G., et al. The epidemiology of multiple sclerosis in Queensland, Australia. J Neurol Sci. 80:1987;185-204
34. Poser C.M., Paty D.W., Scheinberg L., McDonald W.I., Davis F.A., Ebers G.C., et al. New diagnostic criter for multiple sclerosis: guidelines for research protocols. Ann Neurol. 13:1983;227-231
35. Deibler G.E., Martenson R.E., Kies M.W. Large scale preparation of myelin basic protein from central nervous tissue of several mammalian species. Prep Biochem Biotechnol. 2:1972;139-165
36. Markovic-Plese S., Fukaura H., Zhang J., al-Sabbagh A., Southwood S., Sette A., et al. T cell recognition of immunodominant and cryptic proteolipid epitopes in humans. J Immunol. 155:1995;982-992
37. Mock B.A., Nacy C.A. Hormonal modulation of sex differences in resistance to Leishmania major systemic infections. Infect Immun. 56:1988;3316-3319
38. Huygen K., Palfliet K. Strain variation in interferon gamma production of BCG-sensitized mice challenged with PPD II. Importance of one major autosomal locus and additional sexual influences. Cell Immunol. 85:1984;75-81
39. Fox H.S., Bond B.L., Parslow T.G. Estrogen regulates the IFN-gamma promoter. J Immunol. 146:1991;4362-4367
40. Weinstein Y., Ran S., Segal S. Sex-associated differences in the regulation of immune responses controlled by the MHC of the mouse. J Immunol. 132:1984;656-661
41. Cutolo M., Sulli A., Seriolo B., Accardo S., Masi A.T. Estrogens, the immune response and autoimmunity. Clin Exp Rheumatol. 13:1995;217-226
42. Amadori A., Zamarchi R., De Silvestro G., Forza G., Cavatton G., Danieli G.A., et al. Genetic control of the CD4/CD8 T-cell ratio in humans. Nat Med. 1:1995;1279-1283
43. Willard H.F., Riordan J.R. Assignment of the gene for myelin proteolipid protein to the X chromosome: implications for X-linked myelin disorders. Science. 230:1985;940-942
44. Macklin W.B., Campagnoni C.W., Deininger P.L., Gardinier M.V. Structure and expression of the mouse myelin proteolipid protein gene. J Neurosci Res. 18:1987;383-394
45. Derbinski J., Schulte A., Kyewski B., Klein L. Promiscuousgene expression in medullary thymic epithelial cells mirrors the peripheral self. Nat Immunol. 2:2001;1032-1039
46. Tornwall J., Carey A.B., Fox R.I., Fox H.S. Estrogen in autoimmunity: expression of estrogen receptors in thymic and autoimmune T cells. J Gend Specif Med. 2:1999;33-40
47. Melcangi R.C., Magnaghi V., Galbiati M., Martini L. Steroid effects on the gene expression of peripheral myelin proteins. Horm Behav. 40:2001;210-214
48. Cheng Q., Jiang G.X., Press R., Andersson M., Ekstedt B., Vrethem M., et al. Clinical epidemiology of Guillain-Barre syndrome in adults in Sweden 1996-97: a prospective study. Eur J Neurol. 7:2000;685-692
49. +, memory T cells recognizing proteolipid protein from neurologically normal subjects. Cell Immunol. 212:2001;44-50
50. Schwartz M., Kipnis J. Multiple sclerosis as a by-product of the failure to sustain protective autoimmunity: a paradigm shift. Neuroscientist. 8:2002;405-413
51. Runmarker B., Andersen O. Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up. Brain. 116:1993;117-134
52. Hauben E., Mizrahi T., Agranov E., Schwartz M. Sexual dimorphism in the spontaneous recovery from spinal cord injury: a gender gap in beneficial autoimmunity? Eur J Neurosci. 16:2002;1731-1740
53. Burns J., Bartholomew B., Lobo S. Isolation of myelin basic protein-specific T cells predominantly from the memory T-cell compartment in multiple sclerosis. Ann Neurol. 45:1999;33-39
54. Scholz C., Patton K.T., Anderson D.E., Freeman G.J., Hafler D.A. Expansion of autoreactive T cells in multiple sclerosis is independent of exogenous B7 costimulation. J Immunol. 160:1998;1532-1538
55. Lovett-Racke A.E., Trotter J.L., Lauber J., Perrin P.J., June C.H., Racke M.K. Decreased dependence of myelin basic protein-reactive T cells on CD28-mediated costimulation in multiple sclerosis patients. A marker of activated/memory T cells. J Clin Invest. 101:1998;725-730